228 related articles for article (PubMed ID: 11522644)
21. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA
Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118
[TBL] [Abstract][Full Text] [Related]
22. Abrupt reduction of c-myc expression by antisense RNA inducing terminal differentiation and apoptosis of a human esophageal cancer cell line.
Zhao X; Wang X; Zhou C; Peng R; Yan S; Wu M
Sci China B; 1995 May; 38(5):580-9. PubMed ID: 7626199
[TBL] [Abstract][Full Text] [Related]
23. Deregulated c-myc expression overrides IFN gamma-induced macrophage growth arrest.
Vairo G; Vadiveloo PK; Royston AK; Rockman SP; Rock CO; Jackowski S; Hamilton JA
Oncogene; 1995 May; 10(10):1969-76. PubMed ID: 7761098
[TBL] [Abstract][Full Text] [Related]
24. c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin(-)Sca-1(+)c-Kit(-) cell generation through p21.
Baena E; Ortiz M; Martínez-A C; de Alborán IM
Exp Hematol; 2007 Sep; 35(9):1333-43. PubMed ID: 17637497
[TBL] [Abstract][Full Text] [Related]
25. Cooperation of MLL/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model.
Fu JF; Liang ST; Huang YJ; Liang KH; Yen TH; Liang DC; Shih LY
Int J Cancer; 2017 Mar; 140(5):1159-1172. PubMed ID: 27859216
[TBL] [Abstract][Full Text] [Related]
26. Constitutive expression of exogenous myc in myelomonocytic cells: acquisition of a more transformed phenotype and inhibition of differentiation induction.
Chisholm O; Stapleton P; Symonds G
Oncogene; 1992 Sep; 7(9):1827-36. PubMed ID: 1501891
[TBL] [Abstract][Full Text] [Related]
27. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
[TBL] [Abstract][Full Text] [Related]
28. Aberrant dendritic cell differentiation initiated by the Mll-Een fusion gene does not require leukemic transformation.
Sun Q; Kong CT; Huang FP; Chan LC
J Leukoc Biol; 2008 Jan; 83(1):173-80. PubMed ID: 17895399
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.
Liu T; Jankovic D; Brault L; Ehret S; Baty F; Stavropoulou V; Rossi V; Biondi A; Schwaller J
Leukemia; 2010 Mar; 24(3):601-12. PubMed ID: 20072157
[TBL] [Abstract][Full Text] [Related]
30. Activation of the M-CSF gene in mouse macrophages immortalized by retroviruses carrying a v-myc oncogene.
Righi M; Sassano M; Valsasnini P; Shammah S; Ricciardi-Castagnoli P
Oncogene; 1991 Jan; 6(1):103-11. PubMed ID: 1825138
[TBL] [Abstract][Full Text] [Related]
31. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
32. Role of myc in the abrogation of IL3 dependence of myeloid FDC-P1 cells.
Dean M; Cleveland JL; Rapp UR; Ihle JN
Oncogene Res; 1987 Aug; 1(3):279-96. PubMed ID: 2453016
[TBL] [Abstract][Full Text] [Related]
33. Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion gene.
Ninomiya M; Abe A; Yokozawa T; Ozeki K; Yamamoto K; Ito M; Ito M; Kiyoi H; Emi N; Naoe T
Cancer Genet Cytogenet; 2006 Aug; 169(1):1-11. PubMed ID: 16875930
[TBL] [Abstract][Full Text] [Related]
34. Mutants of a multipotent hematopoietic cell line blocked in GM-CSF-induced differentiation are leukemogenic in vivo.
Just U; Spooncer E; Löhler J; Stocking C; Ostertag W; Dexter TM
Exp Hematol; 1994 Aug; 22(9):933-40. PubMed ID: 8062891
[TBL] [Abstract][Full Text] [Related]
35. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
Zeisig BB; Milne T; García-Cuéllar MP; Schreiner S; Martin ME; Fuchs U; Borkhardt A; Chanda SK; Walker J; Soden R; Hess JL; Slany RK
Mol Cell Biol; 2004 Jan; 24(2):617-28. PubMed ID: 14701735
[TBL] [Abstract][Full Text] [Related]
36. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.
Cozzio A; Passegué E; Ayton PM; Karsunky H; Cleary ML; Weissman IL
Genes Dev; 2003 Dec; 17(24):3029-35. PubMed ID: 14701873
[TBL] [Abstract][Full Text] [Related]
37. MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte-macrophage maturation in AML-M5 THP-1 cells.
Pession A; Martino V; Tonelli R; Beltramini C; Locatelli F; Biserni G; Franzoni M; Freccero F; Montemurro L; Pattacini L; Paolucci G
Oncogene; 2003 Nov; 22(54):8671-6. PubMed ID: 14647461
[TBL] [Abstract][Full Text] [Related]
38. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.
Lavau C; Szilvassy SJ; Slany R; Cleary ML
EMBO J; 1997 Jul; 16(14):4226-37. PubMed ID: 9250666
[TBL] [Abstract][Full Text] [Related]
39. The myc gene family proteins and their role in transformation and differentiation.
Ingvarsson S
Semin Cancer Biol; 1990 Dec; 1(6):359-69. PubMed ID: 2103508
[TBL] [Abstract][Full Text] [Related]
40. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.
Santillan DA; Theisler CM; Ryan AS; Popovic R; Stuart T; Zhou MM; Alkan S; Zeleznik-Le NJ
Cancer Res; 2006 Oct; 66(20):10032-9. PubMed ID: 17047066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
